1. Events
  2. Venues
  3. Virtual
Virtual Get Directions
Current

FibroGen Virtual KOL Investor Event Series Part I: Review Pamrevlumab Clinical Program in Pancreatic Cancer and Its Two Near Term Readouts

Join FibroGen for Part I of a virtual KOL investor event series featuring Andrew Ko, MD (University of California San…
TIME: 10:30 AM EST
LOCATION: Virtual
View Details

Antengene’s 2023 Virtual R&D Day: Clinical Update on Key Cancer Targets (CD24, PD-L1/4-1BB, Claudin 18.2, CD73) Featuring a KOL Session on Tumor Immunotherapy

Dr. Anthony J. Olszanski, M.D., RPh (Fox Chase Cancer Center) will join Antengene for their 2023 R&D Day. During the event, Antengene’s…
TIME: 8:30 AM EST
LOCATION: Virtual
View Details

Lumos Pharma Virtual KOL Event: Review of Phase 2 OraGrowtH Trials and New Analyses of Oral LUM-201 for Pediatric Growth Hormone Deficiency

Join Lumos Pharma for a virtual KOL event featuring Andrew Dauber, M.D., M.M.Sc.,(Children’s National Hospital), Fernando Cassorla, M.D. (Institute of…
TIME: 1:30 PM EST
LOCATION: Virtual
View Details

VirtualXilio Therapeutics Investor Webcast – Pipeline Progress and SITC Update

View the webcast here.
TIME: 8:00 AM EST
LOCATION: Virtual
View Details